Serum cystatin C level as a potentially good marker for impaired kidney function

Current clinical practice often relies on creatinine-based estimates of kidney function. However, creatinine has limitations due to variability in muscle mass and secretion. Alternative markers are needed for more accurate assessments. Prior research has shown that creatinine clearance correlates with glomerular filtration rate but lacks precision in certain populations. No prior work had resolved whether cystatin C could serve as a more reliable alternative. This gap motivated the search for a more stable and sensitive biomarker. Researchers have proposed that cystatin C may offer advantages due to its consistent production and filtration. The uncertainty around cystatin C's performance compared to other markers drove this investigation. No prior work had resolved whether cystatin C could replace creatinine in routine diagnostics. That uncertainty prompted this study to evaluate its potential.

The goal was to assess whether serum cystatin C could serve as a diagnostic marker for impaired kidney function. Researchers aimed to compare cystatin C with creatinine and beta(2)-microglobulin in estimating glomerular filtration rate. They sought to determine if cystatin C provides better diagnostic accuracy than existing markers. The study focused on patients with moderate kidney dysfunction and age-matched controls. The motivation was to identify a more reliable and less variable biomarker than creatinine. No prior work had resolved whether cystatin C could outperform creatinine in this context. The researchers proposed that cystatin C might offer higher sensitivity and specificity. This study aimed to establish cutoff values and evaluate the diagnostic performance of cystatin C.

The study compared serum (99m)Tc-DTPA clearance with cystatin C, creatinine, and beta(2)-microglobulin in 52 patients and 52 controls. Glomerular filtration rates ranged from 10 to 60 mL/min/1.73 m² in the patient group. Blood samples were collected at three time points to assess consistency of cystatin C levels. No significant differences were observed between repeated measurements in healthy subjects. Correlation analysis was performed between reference clearance and each biomarker. Receiver-operating characteristic curves were used to determine diagnostic accuracy. Cut-off points, sensitivity, and specificity were calculated for each marker. The study design allowed for direct comparison of diagnostic performance across markers.

Cystatin C showed strong correlation with reference clearance (r = 0.828) compared to creatinine (r = 0.682). The optimal cut-off for cystatin C was 1.36 mg/L with 98% sensitivity and 99% specificity. Creatinine had lower sensitivity (80%) but 100% specificity at a cut-off of 103 micromol/L. Beta(2)-microglobulin had intermediate performance with 86% sensitivity and 92% specificity. The area under the curve for cystatin C was 0.99, higher than creatinine (0.97) and beta(2)-microglobulin (0.94). No significant sex-based differences were found in cystatin C levels. Age-related increases in cystatin C were observed but not in creatinine or beta(2)-microglobulin. Repeated measurements showed stable cystatin C levels in healthy individuals.

The authors propose that serum cystatin C may serve as a diagnostic marker for impaired kidney function. They suggest that cystatin C offers higher sensitivity than creatinine while maintaining high specificity. No prior work had resolved whether cystatin C could replace creatinine in clinical diagnostics. The study supports the use of cystatin C as a more reliable alternative to creatinine. The researchers propose that cystatin C may be particularly useful in populations where creatinine is less accurate. The findings suggest that cystatin C could improve diagnostic accuracy in estimating glomerular filtration rate. No prior work had resolved whether cystatin C could outperform beta(2)-microglobulin in this context. The authors suggest that further studies are needed to confirm these findings in larger populations.